Carregant...

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer

BACKGROUND: Relatives of BRCA1 and BRCA2 mutation carriers have long been proposed by epidemiological studies to have an increased risk of developing prostate cancer. In the Ashkenazi Jewish (AJ) population, the existence of 3 frequent founder mutations, 185delAG and 5382insC in BRCA1 and 6174delT i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hamel, Nancy, Kotar, Kimberley, Foulkes, William D
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2003
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC194219/
https://ncbi.nlm.nih.gov/pubmed/12911837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2350-4-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!